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Initial + 16ml XOD +32 mL XOD
HA 0.8% MW 787 000 Da 621 450 Da 498 900 Da
Mannitol 3.5% + HA 0.8% MW 768 900 Da 717 750 Da 677 150 Da
1st 5th Change
SF volume (ml) 14.2 7.3 6.9 P < 0.05
HA (mg/ml) 1.50 1.72 0.22 P < 0.05
C4S (nmol/ml) 17.5 16.0 1.5 P < 0.05
C6s (nmol/ml) 59.7 50.2 9.5 P < 0.05
KS (mg/ml) 6.62 6.23 0.39 NS
IL-6 (pg/ml) 3733 457 3276 P < 0.05
Viscosity (mPa∙S) 49.6 72.5 22.9 P < 0.05
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component of synovial ﬂuid), the nanoparticles are recovered with HA
in order to enhance targeting of cells. Here, we have studied the
internalization kinetics of “empty” nanoparticles, and we have eval-
uated their neutrality on chondrocytes matrix synthesis, mesenchymal
stem cell (MSC) differentiation and inﬂammatory response. Innocuity
has been also evaluated in healthy animals, after direct intraarticular
injection of labelled nanoparticles (inﬂammatory response, Extrac-
ellular matrix integrity).
Methods: Articular cells (chondrocytes, synoviocytes) and MSC are
isolated from human donors, and cultured as primary culture. First, cells
are exposed with 100 mg/mL of NPs from 2 to 12 hours. At the end of the
kinetic immunoﬂuorescence pictures with DAPI (nuclear staining) are
realized to assess of the internalization of NPs, expression of inﬂam-
matory markers (IL1ß, TNFa and Cox2) are monitored by RT-qPCR
analysis, and conﬁrmed by PGE2 and nitrites measurement in
supernatant.
In other hand we evaluate, with pellets culture system, the effect of NPs
exposition on extracellular matrix synthesis by chondrocytes, with RT-
qPCR analysis of speciﬁc markers (Col2, Aggrecan and COMP), and by
histological study of pellets (Alcian blue staining of proteoglycans, Sirius
Red staining of collagen). Finally by growing MSC into 3 different dif-
ferentiation media, we investigate if NPs pre-treatment can interfere
with differentiation ability of MSC onto chondrogenic, adipogenic or
osteogenic pathway. RT-qPCR assays for differentiation markers
according to culture conditions and speciﬁc staining of lipid vesicles or
calcium deposits, allow us to conﬁrm the differentiation of cells.
Intraarticular injections were realized in healthy rat’s Knees. Structure
of joint (synovium, cartilage, subchondral bone) was assessed by his-
tological studies, performed at 7 and 10 days after injection (single and
repeated).
Results: For the different cell types, NPs are found into cytoplasm after
6 hours of exposition.
Internalization of these NPs leads to an increase of inﬂammatory
markers between 4 and 8 hours, basal level of expression being reached
after 12 hours. Even if there is a weak increase of PGE2 and nitrites
synthesis, that stay signiﬁcantly lower than with LPS stimulation, our
positive control of inﬂammation. NPs exposure, prior or after IL-1ß
stimulation, does not aggravate the inﬂammatory response of these
cells. When chondrocytes are exposed to NPs for 24 hours and then
cultured in pellets for 28 days, there is no difference in matrix synthesis
for the expression of mRNA and matrix deposition, as conﬁrmed with
histological exams. RT-qPCR and staining assays have also shown that
despite a pretreatment with NPs, MSCs can be conducted onto adipo-
genic, osteogenic or chondrogenic differentiation pathways. Histo-
logical analyses of extracellular matrix integrity and inﬂammatory
status do not demonstrate any differences for cartilage and subchondral
bone structures but reveal a weak hyperplasia of synovial membrane,
increasing with NPs concentration and the number of injection.
Conclusions: These NPs are rapidly internalized by human articular
cells, with only moderated and transient pro-inﬂammatory effects. In
addition there is no side effects on (1) ECM synthesis by chondrocytes
or MSC and (2) differentiation process due to the presence of NPs.
Labelled NPs with Cya3, once injected in joint of healthy rat, do not lead
to an inﬂammatory reaction and/or modiﬁcation of extracellular matrix
integrity. NPs are mainly found in synovium and repeated injections do
not generate severe adverse reaction. This drug delivery system can be
used to deliver an active molecule into the knee joint, thanks to the
absence of side effects.
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ROLE OF HIGH CONCENTRATIONS OF MANNITOL ON THE STABILITY
OF HYALURONAN IN AN OXIDATIVE STRESS MODEL INDUCED BY
XANTHINE/XANTHINE OXYDASE
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France; zUniv. Joseph Fourier, GREPI AGIM FRE 3405 CNRS, Grenoble,
France; xBiomaterials Applications, Grenoble, France
Purpose: Osteoarthritis(OA) is a degenerative joint disease associated
with harmful action of reactive oxygen species (ROS). ROS are involved
in the degradation of both aggrecan and high-molecular-weight hya-
luronan (HMW-HA). The later plays a key-role in the joint lubrication
and the visco-elastic and shock absorbing properties of the synovial
ﬂuid (SF). Viscosupplementation consists to inject intraarticularly
exogenous HMW-HA to restore the SF rheological properties, that aredramatically decreased in OA. However the injected HA is also rapidly
degradated by ROS, decreasing its effectiveness and duration of action.
The study objective was to evaluate the ability of Mannitol, a powerful
oxygen free radical scavenger, to reduce HMW-HA ROS mediated deg-
radation using a model of oxydative stress induced by xanthine (X) þ
xanthine oxidase (XOD). XOD is a ﬂavoprotein that catalyzes oxidation
of hypoxanthine to xanthine and then to uric acid generating high levels
of superoxide anion.
Methods: Hyaluronan (MW# 0.8mDa) was submitted to an oxidative
stress generated by the addition of X þ XOD. Then solution of the same
HA þ 35g/L of Mannitol in PBS buffer was studied. Different enzyme
concentrations were used and the HA properties were studied after 24
hours of contact at ambient temperature. Changes of the viscosity of the
solution were assessed by rheometry with a rheometer at 25 C using a
cone and plate geometry; steady-state viscosity was determined in Pa.s,
as a function of the shear rate. HA MW was also determined by steric
exclusion chromatography before and after oxydative stress.
Results: The presence of X/XOD degraded HA : 1) HA viscosity
decreased as a function of XOD concentration, 2) HA MW decreased
dramatically by 36.6%.On the opposite the presence of Mannitol stabi-
lized HA : 1) HA viscosity remained stable, 2) HA MW decreased only
slightly (-11.9%).
Conclusions: High concentrations (35g/L) of mannitol protect HA from
ROS-mediated degradation. These in vitro data suggest that mannitol
may increase the intra-articular residence time of HA and consequently
may improve efﬁcacy and/or effectiveness duration of viscosupple-
mentation.
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CHANGES OF THE BIOMARKERS IN SYNOVIAL FLUID AND CLINICAL
EFFICACY OF INTRA-ARTICULAR INJECTION HYALURONIC ACID FOR
PATIENTS WITH KNEE OSTEOARTHRITIS
Y. Kusayama y, Y. Akamatsu y, K. Kumagai y, H. Kobayashi y,
A. Nakazawa z, T. Saito y. yYokohama city Univ., Kanagawa prefecture
Yokohama city, Japan; zYokohama Municipal Citizen’s Hosp., Kanagawa
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Purpose: Intra-articular injection hyaluronic acid (HA) for the treat-
ment of patients with knee osteoarthritis (OA) has been commonly used
in Japan. However, American Academy of Orthopaedic Sugerons (AAOS)
announced intra-articular hyaluronic acid is no longer recommended in
the 2013 guideline. Efﬁcacy of the intra-articular HA still remain con-
troversial. We have performed ﬁve weekly HA injections according to
the Japanese insurance policy. Many biomarkers are reported: some
biomarkers reﬂects cartilage metabolism and the others reﬂects
inﬂammation reaction. We examined HA, chondroitin 4-sulfate (C4S),
chondroitin 6-sulfate (C6S), keratan sulfate (KS) for cartilage metabolic
biomarker and interleuikin-6 (IL-6) for inﬂammation biomarker. Il-6 is
well known as inﬂammation cytokine in the patients with rheumatoid
arthritis, but the change of Il-6 levels treated by the intra-articular HA in
the patients with OA has not been reported. The purpose of this study
was to investigate the change of the viscosity and biomarkers of
synovial ﬂuid and clinical symptoms before and after ﬁve weekly HA
injections.
Methods: Fifty seven patients (61 knees) with symptomatic knee OA
were enrolled between January 2010 and July 2013. We conducted 5
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Japan) after drainage of synovial ﬂuid in every cases. We checked total
volume of synovial ﬂuid (SF) and measured: HA, C4S, C6S, KS and IL-6
before ﬁrst and ﬁfth time. Viscosity measurement was performed by
using rotational viscometers. We excluded the case if synovial ﬂuid
could not be extracted. We decided not to administer aspirin and
nonsteroidal anti-inﬂammatory drugs six weeks before injections and
during injections. The range of motion was measured and clinical
symptoms were using American Knee Society (AKS) knee and function
scores. All knees were classiﬁed using the Kellgren-Lawrence grades (KL
grade), and the femorotibial angle (FTA) was measured on the
radiogram.
Results: Eighteen patients (18 knees) were not extracted before ﬁn-
ished 5 weekly injections, they were excluded. Forty three knees (right
23 and left 20 knees) were examined. Mean age was 66  9.5 years old,
and mean body mass index was 23.7  2.6 kg/mz. KL grades were grade
1 in 3 knees, grade 2 in 24 knees, grade 3 in 14 knees and grade 4 in 2
knees. Mean FTA was 178.8  3.6. We didn’t have complications and
side effects. The volume of SF, which was 14.2ml before ﬁrst injection
and 7.3 ml before ﬁfth injection, signiﬁcantly decreased after HA
injections (p < 0.05). Mean AKS knee score, which was 61 points before
ﬁrst injection and 77 points before ﬁfth injection signiﬁcantly improved
after HA injections (p < 0.05). Mean AKS function score, which was 75
points before ﬁrst injection and 91 points before ﬁfth injection, sig-
niﬁcantly improved after HA injections (p < 0.05). Mean ROM, which
was 129  10 before ﬁrst injection and 137  7 before ﬁfth injection,
signiﬁcantly improved after HA injections (p< 0.05). Mean HA level was
signiﬁcantly increased from 1.50 mg/ml to 1.72 mg/ml (P < 0.05). Mean
C4S and C6S level were signiﬁcantly decreased from 17.5 nmol/ml to
16.0 nmol/ml and from 59.7 nmol/ml to 50.2 nmol/ml, respectively (P <
0.05). Mean KS level was not signiﬁcantly decreased from 6.62 mg/ml to
6.23 mg/ml. Mean IL-6 level was signiﬁcantly decreased from 3733 pg/
ml to 457 pg/ml (P < 0.05). The mean viscosity was signiﬁcantly
increased from 49.6 mPa･S to 72.5 mPa･S (P < 0.05).
Conclusions: The increase of HA and viscosity showed the nature of
synovial ﬂuid was improved. The decrease of C6S and C4S showed the
destruction of proteoglycan in articular cartilage was inhibited. The
decrease of IL-6 showed the inﬂammation of synoviumwas suppressed.
This study was ﬁrst report to indicate that IL-6 was decreased after
intra-articular HA. We demonstrated changes of the biomarkers, the
improvement of clinical scores and efﬁcacy of intra-articular HA.
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MATERIAL ON THE BASIS OF PARTIALLY CROSSLINKED SOLUTION OF
HA DERIVATIVE FOR SYNOVIAL FLUID VISCOSUPPLEMENTATION
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Purpose: Synovial ﬂuid is a joint lubricant and plays an important role in
cartilage deformation caused by mechanical load. The main component
of synovial ﬂuid is hyaluronic acid with an approximate concentration of
2,5mg/ml and the averagemolecularweight of 3-5MDa in healthy joints.
It is known, that during osteoarthritis the concentration and the average
molecular weight of HA in synovial ﬂuid are signiﬁcantly reduced. This
has a negative effect on the viscoelasticity of the synovial ﬂuid, which
leads to signiﬁcant decrease of themechanical protection of the articular
system. Also, the articular cartilage function deteriorates. It is also known
that preparationswith loweraveragemolecularweightused in treatment
have not sufﬁcient viscoelastic properties and undergo biodegradation
too quickly. In our previous work we designed a new HA tyramine
derivative for the preparation of non-cytotoxic and biocompatible HA
hydrogel-basedmaterialswith enhancedmechanical properties. This HA
derivative was further optimized to become a material with suitable
properties for synovial ﬂuid viscosupplementation. For this purpose,
partially crosslinked solutions with prolonged biostability compared to
HA solution-based treatment preparations, were designed. In this work
we would like to present viscoelastic properties of this material and
results from in vivo tests, in which this material was evaluated in treat-
ment of experimentally induced osteoarthritis in rabbit knee.
Methods: In this study viscoelastic properties of new designed partially
crosslinked HA-based solutions were determined and optimized to
reach the appropriate properties corresponding with synovial ﬂuid. The
viscoelastic properties were measured by dynamic mechanical analysisin a frequency sweep oscillation mode (frequency 0, 1-10 Hz at 0, 5%
strain) and bydetermination of storagemodulusG0, lossmodulus G00 and
loss angle d. After that the treatment effect of our newdesignedmaterial
was tested in rabbit knee. Experimental osteoarthritis was induced in
male rabbit outbred line P91 by intraarticular injection of collagenase.
The rabbitswere intraarticularly injectedwith ourmaterial immediately
after the osteoarthritis induction and then repeatedly once aweek in the
course of 5 weeks. The volume of the intraarticularly injected substance
was 0, 3 ml. Animals treated with physiological solution as control and
animals treated with HA solution-based commercial product as positive
controls were also included in the tests. After 8 weeks, the rabbit carti-
lagesweremacromorphometrically evaluated. The cartilageswere post-
mortem inspected and gross morphological changes of the medial and
lateral condyles were rated according to the criteria published by
Yoshioka et al.[1, 2]: grade 1 - intact surface; grade 2 - slightly rough
surface, minimal ﬁbrillation and erosions; grade 3 - markedly rough
surface, ﬁbrillation and hypertrophic cartilage with moderate erosions;
grade 4 - severe erosions, loss of cartilage exposing the underlying bone.
Histological evaluation was also performed.
Results:
Fig.1: Representative results obtained from Dynamic mechanical anal-
ysis in a frequency sweep oscillation mode (frequency 0,1-10 Hz at 0, 5%
strain) of our new designed HA-basedmaterial and commercial product
used as a positive control
Fig.2: Results obtained from the evaluation of morphological changes in
OA rabbit knee rated according the criteria mentioned above
Conclusions: The results obtained so far showed that our new designed
material has suitable properties for synovial ﬂuid viscosupplementa-
tion. Thanks to the partial crosslinking of the HA solutions, our material
has enhanced viscoelastic properties and prolonged biostability com-
pared to HA solution-based treatment preparations with insufﬁcient
molecular weight. The results from in vivo tests showed that the
intraarticular injections of our material prevent the development of
joint damage in the rabbit model of osteoarthritis. The morphological
changes demonstrate a substantial decrease in severity of the damage
caused in condyle cartilage.
